No Cover Image

Journal article 839 views 259 downloads

Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetes

Rose Anderson, Jennifer Hayes, Jeffrey Stephens Orcid Logo

Expert Opinion on Drug Metabolism & Toxicology, Volume: 12, Issue: 4, Pages: 467 - 473

Swansea University Author: Jeffrey Stephens Orcid Logo

Check full text

DOI (Published version): 10.1517/17425255.2016.1154044

Published in: Expert Opinion on Drug Metabolism & Toxicology
ISSN: 1744-7607
Published: 2016
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa26718
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2016-03-10T02:00:06Z
last_indexed 2018-02-09T05:09:00Z
id cronfa26718
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2016-04-12T15:21:30.9066590</datestamp><bib-version>v2</bib-version><id>26718</id><entry>2016-03-09</entry><title>Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetes</title><swanseaauthors><author><sid>5219d126f97f8f884bdb622099bd41de</sid><ORCID>0000-0003-2228-086X</ORCID><firstname>Jeffrey</firstname><surname>Stephens</surname><name>Jeffrey Stephens</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2016-03-09</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Expert Opinion on Drug Metabolism &amp; Toxicology</journal><volume>12</volume><journalNumber>4</journalNumber><paginationStart>467</paginationStart><paginationEnd>473</paginationEnd><publisher/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>1744-7607</issnElectronic><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2016</publishedYear><publishedDate>2016-12-31</publishedDate><doi>10.1517/17425255.2016.1154044</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2016-04-12T15:21:30.9066590</lastEdited><Created>2016-03-09T10:50:18.9586668</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Rose</firstname><surname>Anderson</surname><order>1</order></author><author><firstname>Jennifer</firstname><surname>Hayes</surname><order>2</order></author><author><firstname>Jeffrey</firstname><surname>Stephens</surname><orcid>0000-0003-2228-086X</orcid><order>3</order></author></authors><documents><document><filename>0026718-09032016110316.pdf</filename><originalFilename>Saxagliptin,__Anderson__et__al,__Accepted__revision.pdf</originalFilename><uploaded>2016-03-09T11:03:16.8970000</uploaded><type>Output</type><contentLength>395869</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2017-03-01T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect></document></documents><OutputDurs/></rfc1807>
spelling 2016-04-12T15:21:30.9066590 v2 26718 2016-03-09 Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetes 5219d126f97f8f884bdb622099bd41de 0000-0003-2228-086X Jeffrey Stephens Jeffrey Stephens true false 2016-03-09 BMS Journal Article Expert Opinion on Drug Metabolism & Toxicology 12 4 467 473 1744-7607 31 12 2016 2016-12-31 10.1517/17425255.2016.1154044 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2016-04-12T15:21:30.9066590 2016-03-09T10:50:18.9586668 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Rose Anderson 1 Jennifer Hayes 2 Jeffrey Stephens 0000-0003-2228-086X 3 0026718-09032016110316.pdf Saxagliptin,__Anderson__et__al,__Accepted__revision.pdf 2016-03-09T11:03:16.8970000 Output 395869 application/pdf Accepted Manuscript true 2017-03-01T00:00:00.0000000 true
title Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetes
spellingShingle Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetes
Jeffrey Stephens
title_short Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetes
title_full Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetes
title_fullStr Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetes
title_full_unstemmed Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetes
title_sort Pharmacokinetic, pharmacodynamic and clinical evaluation of saxagliptin in type 2 diabetes
author_id_str_mv 5219d126f97f8f884bdb622099bd41de
author_id_fullname_str_mv 5219d126f97f8f884bdb622099bd41de_***_Jeffrey Stephens
author Jeffrey Stephens
author2 Rose Anderson
Jennifer Hayes
Jeffrey Stephens
format Journal article
container_title Expert Opinion on Drug Metabolism & Toxicology
container_volume 12
container_issue 4
container_start_page 467
publishDate 2016
institution Swansea University
issn 1744-7607
doi_str_mv 10.1517/17425255.2016.1154044
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2016-12-31T03:32:08Z
_version_ 1763751314315018240
score 10.998116

Similar Items